F Hentschel1, M Kreis, M Damian, B Krumm, L Frölich. 1. Division for Neuroradiology, Central Institute for Mental Health, Faculty for Clinical Medicine Mannheim, University of Heidelberg, Germany. hentsche@zi-mannheim.de
Abstract
OBJECTIVES: The individual contribution to the final comprehensive clinical diagnosis of neuropsychology (NP) and magnetic resonance imaging (MRI), respectively, was quantified in a specialized tertiary care setting to investigate the added clinical value of routine MRI. METHODS: In 106 patients referred to a university memory clinic for the work-up of cognitive disturbances the primary care diagnosis, the initial clinical neuropsychiatric diagnosis, the neuropsychological and MRI diagnoses, and the final comprehensive clinical diagnosis were documented. The neuropsychological investigation was performed using the CERAD test battery. MRI was performed using T1, double echo and FLAIR sequences without contrast medium. The change of the final comprehensive clinical diagnosis in relation to the initial neuropsychiatric diagnosis was used to determine the diagnostic contribution of both, MRI and NP. RESULTS: NP and MRI led to a significant change of the final comprehensive diagnosis in 26% of patients (CI: 0.26 +/- 0.09; p < 0.05). In addition, three cases of secondary dementias, and six cases of vascular encephalopathy without dementia were recognized by MRI. Sensitivity, specificity, and the positive predictive value were higher for NP and MRI, respectively, than for the initial clinical diagnosis alone. CONCLUSION: MRI as well as neuropsychological testing improves early detection and differential diagnosis of dementia and additionally supplies clinically relevant findings. MRI carries added clinical value in the investigation of dementias. Copyright 2005 John Wiley & Sons, Ltd.
OBJECTIVES: The individual contribution to the final comprehensive clinical diagnosis of neuropsychology (NP) and magnetic resonance imaging (MRI), respectively, was quantified in a specialized tertiary care setting to investigate the added clinical value of routine MRI. METHODS: In 106 patients referred to a university memory clinic for the work-up of cognitive disturbances the primary care diagnosis, the initial clinical neuropsychiatric diagnosis, the neuropsychological and MRI diagnoses, and the final comprehensive clinical diagnosis were documented. The neuropsychological investigation was performed using the CERAD test battery. MRI was performed using T1, double echo and FLAIR sequences without contrast medium. The change of the final comprehensive clinical diagnosis in relation to the initial neuropsychiatric diagnosis was used to determine the diagnostic contribution of both, MRI and NP. RESULTS: NP and MRI led to a significant change of the final comprehensive diagnosis in 26% of patients (CI: 0.26 +/- 0.09; p < 0.05). In addition, three cases of secondary dementias, and six cases of vascular encephalopathy without dementia were recognized by MRI. Sensitivity, specificity, and the positive predictive value were higher for NP and MRI, respectively, than for the initial clinical diagnosis alone. CONCLUSION: MRI as well as neuropsychological testing improves early detection and differential diagnosis of dementia and additionally supplies clinically relevant findings. MRI carries added clinical value in the investigation of dementias. Copyright 2005 John Wiley & Sons, Ltd.
Authors: F Streitparth; G Wieners; A Kämena; R J Schröder; H Stiepani; T Kokocinski; R Röttgen; E Steinhagen-Thiessen; R Lenzen-Grossimlimghaus; N Hidajat Journal: Radiologe Date: 2008-02 Impact factor: 0.635
Authors: H Qureischie; R Heun; J Popp; F Jessen; W Maier; S Schmitz; F Hentschel; P Kelemen; H Kölsch Journal: J Neural Transm (Vienna) Date: 2009-01-28 Impact factor: 3.575
Authors: Winnie S Liang; Travis Dunckley; Thomas G Beach; Andrew Grover; Diego Mastroeni; Keri Ramsey; Richard J Caselli; Walter A Kukull; Daniel McKeel; John C Morris; Christine M Hulette; Donald Schmechel; Eric M Reiman; Joseph Rogers; Dietrich A Stephan Journal: Physiol Genomics Date: 2008-02-12 Impact factor: 3.107
Authors: Dinesh K Deelchand; Isaac M Adanyeguh; Uzay E Emir; Tra-My Nguyen; Romain Valabregue; Pierre-Gilles Henry; Fanny Mochel; Gülin Öz Journal: Magn Reson Med Date: 2014-06-19 Impact factor: 4.668
Authors: Milap A Nowrangi; Christopher Marano; Kenichi Oishi; Susumu Mori; Haris I Sair; John Outen; Jeannie Leoutsakos; Constantine Lyketsos; Paul B Rosenberg Journal: Int Psychogeriatr Date: 2020-02-28 Impact factor: 3.878
Authors: Stefan Klöppel; Jessica Peter; Anna Ludl; Anne Pilatus; Sabrina Maier; Irina Mader; Bernhard Heimbach; Lars Frings; Karl Egger; Juergen Dukart; Matthias L Schroeter; Robert Perneczky; Peter Häussermann; Werner Vach; Horst Urbach; Stefan Teipel; Michael Hüll; Ahmed Abdulkadir Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Arunima Kapoor; Robert Bartha; Sandra E Black; Michael Borrie; Morris Freedman; Fuqiang Gao; Nathan Herrmann; Jennifer Mandzia; Miracle Ozzoude; Joel Ramirez; Christopher J M Scott; Sean Symons; Corinne E Fischer; Andrew Frank; Dallas Seitz; Michael Uri Wolf; Nicolaas Paul L G Verhoeff; Gary Naglie; William Reichman; Mario Masellis; Sara B Mitchell; David F Tang-Wai; Maria Carmela Tartaglia; Sanjeev Kumar; Bruce G Pollock; Tarek K Rajji; Elizabeth Finger; Stephen H Pasternak; Richard H Swartz Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472